Healthcare Services

Necrotizing Enterocolitis Market Future Analysis Covering Industry Shifts And Growth Potential

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Necrotizing Enterocolitis Market Progress Through 2030?

The necrotizing enterocolitis market has experienced substantial growth in recent years. Its value is projected to increase from $5.14 billion in 2025 to $5.47 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. The expansion observed in the historic period stemmed from factors such as a high incidence of premature births, insufficient neonatal care infrastructure, widespread reliance on broad-spectrum antibiotics, challenges in timely diagnosis within low-resource environments, and the initial development of parenteral nutrition.

The necrotizing enterocolitis market is projected to experience robust growth in the upcoming years, with its size anticipated to reach $6.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This expansion during the forecast period can be attributed to factors such as increased investment in neonatal intensive care units, progress in regenerative and stem cell therapies, a rise in awareness for early NEC detection, the expanding adoption of precision nutrition therapies, and the proliferation of neonatal imaging innovations. Key trends foreseen in this period encompass the escalating use of probiotics and prebiotics for NEC prevention, an enhanced emphasis on early diagnosis and screening in premature infants, the wider utilization of individualized TPN solutions, the development of minimally invasive surgical interventions, and ongoing advancements in neonatal critical care and monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22068&type=smp

What Key Growth Drivers Are Influencing The Necrotizing Enterocolitis Market?

The growing incidence of premature births is anticipated to fuel the expansion of the necrotizing enterocolitis market moving forward. Premature births, also known as preterm births, are characterized by the delivery of an infant before 37 weeks of gestation, as opposed to the standard 40-week pregnancy duration. The rising occurrence of premature births is attributed to maternal health problems like high blood pressure, diabetes, and infections, which elevate the risk of preterm labor, as well as lifestyle choices such as smoking, drug use, and inadequate nutrition, all contributing to a higher probability of early delivery. An increase in premature births subsequently leads to more cases of necrotizing enterocolitis (NEC) because premature infants have immature gastrointestinal systems, making them more susceptible to inflammation and infection. For example, in January 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that premature births comprise 8.67% of total annual births in the United States. Hence, the increasing instances of premature births are a key driver for the growth of the necrotizing enterocolitis market.

How Is Segment Classification Applied In The Necrotizing Enterocolitis Market?

The necrotizing enterocolitis market covered in this report is segmented –

1) By Treatment: Total Parenteral Nutrition (TPN), Gastrointestinal Decompression, Antimicrobial Therapy, Antifungal Treatment, Paracentesis, Other Treatments

2) By Diagnosis: Laboratory Tests, Imaging Techniques

3) By Stage: Stage I (Suspected Necrotizing Enterocolitis), Stage II (Definite Necrotizing Enterocolitis), Stage III (Advanced Necrotizing Enterocolitis)

4) By End-User: Hospitals, Neonatal Intensive Care Units (NICUs), Specialty Clinics

Subsegments:

1) By Total Parenteral Nutrition (TPN): Standard TPN Formulations, Customized Or Individualized TPN Solutions, Lipid Emulsions For TPN, Protein And Amino Acid Supplements In TPN, Micronutrient And Electrolyte-Enhanced TPN

2) By Gastrointestinal Decompression: Nasogastric Tube (NG Tube) Decompression, Orogastric Tube Decompression, Surgical Gastrostomy For Decompression, Non-Surgical Decompression Techniques

3) By Antimicrobial Therapy: Broad-Spectrum Antibiotics, Gram-Positive Coverage Antibiotics, Gram-Negative Coverage Antibiotics, Combination Antibiotic Therapy, Prophylactic Antibiotic Strategies For High-Risk Neonates

4) By Antifungal Treatment: Systemic Antifungal Therapy, Prophylactic Antifungal Therapy For Preterm Infants, Combination Antifungal And Antibiotic Therapy For Severe NEC

5) By Paracentesis: Diagnostic Paracentesis, Therapeutic Paracentesis, Guided Paracentesis using Ultrasound Or Radiological Techniques

6) By Other Treatments: Probiotics And Prebiotics for NEC Prevention, Surgical Interventions, Stem Cell Therapy And Regenerative Medicine Approaches, Immunomodulatory Therapies, Supportive Care

Which Trends Are Expected To Shape The Necrotizing Enterocolitis Market?

Which Companies Are Influencing The Necrotizing Enterocolitis Market?

Major companies operating in the necrotizing enterocolitis market are Abbott Laboratories, Astellas Pharma Inc., Mayo Foundation for Medical Education and Research, Cleveland Clinic, Boston Children’s Hospital, Hollister Incorporated, UPMC Children’s Hospital of Pittsburgh, Prolacta Bioscience Inc., Evolve BioSystems, Sigma-Tau Pharmaceuticals, Mead Johnson & Company LLC, Liminal BioSciences Inc., Noveome Biotherapeutics Inc., Infant Bacterial Therapeutics, Prometic Life Sciences Inc., Nexilico, Siolta Therapeutics, ProThera Biologics Inc., Plakous Therapeutics Inc., Chosen Diagnostics Inc.

Access The Complete Necrotizing Enterocolitis Market Report:

https://www.thebusinessresearchcompany.com/report/necrotizing-enterocolitis-global-market-report

Which Region Stands As The Largest Contributor To The Necrotizing Enterocolitis Market?

North America was the largest region in the necrotizing enterocolitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the necrotizing enterocolitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Necrotizing Enterocolitis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=22068&type=smp

Browse Through More Reports Similar to the Global Necrotizing Enterocolitis Market 2026, By The Business Research Company

Lipid Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Antidiabetics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report

Lip Care Product Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lip-care-product-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795